These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9526570)

  • 1. Intensely potent doxorubicin analogues: structure-activity relationship.
    Farquhar D; Cherif A; Bakina E; Nelson JA
    J Med Chem; 1998 Mar; 41(6):965-72. PubMed ID: 9526570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-(5,5-diacetoxypent-1-yl)doxorubicin: a new intensely potent doxorubicin analogue.
    Cherif A; Farquhar D
    J Med Chem; 1992 Aug; 35(17):3208-14. PubMed ID: 1354750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationships for substituted bis(acridine-4-carboxamides): a new class of anticancer agents.
    Gamage SA; Spicer JA; Atwell GJ; Finlay GJ; Baguley BC; Denny WA
    J Med Chem; 1999 Jul; 42(13):2383-93. PubMed ID: 10395479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural features determining activity of phenothiazines and related drugs for inhibition of cell growth and reversal of multidrug resistance.
    Ford JM; Prozialeck WC; Hait WN
    Mol Pharmacol; 1989 Jan; 35(1):105-15. PubMed ID: 2563302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further examination of 9-alkyl- and sugar-modified anthracyclines in the circumvention of multidrug resistance.
    Coley HM; Twentyman PR; Workman P
    Anticancer Drug Des; 1992 Dec; 7(6):471-81. PubMed ID: 1337431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and potent antifolate activity and cytotoxicity of B-ring deaza analogues of the nonpolyglutamatable dihydrofolate reductase inhibitor Nalpha-(4-amino-4-deoxypteroyl)-Ndelta-hemiphthaloyl- L-ornithine (PT523).
    Rosowsky A; Wright JE; Vaidya CM; Bader H; Forsch RA; Mota CE; Pardo J; Chen CS; Chen YN
    J Med Chem; 1998 Dec; 41(26):5310-9. PubMed ID: 9857098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-(4-Aroyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-propenamides as a new class of synthetic histone deacetylase inhibitors. 2. Effect of pyrrole-C2 and/or -C4 substitutions on biological activity.
    Mai A; Massa S; Cerbara I; Valente S; Ragno R; Bottoni P; Scatena R; Loidl P; Brosch G
    J Med Chem; 2004 Feb; 47(5):1098-109. PubMed ID: 14971890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analogues of N alpha-(4-amino-4-deoxypteroyl)-N delta-hemiphthaloyl-L-ornithine (PT523) modified in the side chain: synthesis and biological evaluation.
    Rosowsky A; Vaidya CM; Bader H; Wright JE; Teicher BA
    J Med Chem; 1997 Jan; 40(3):286-99. PubMed ID: 9022795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity studies with cytotoxic anthrapyrazoles.
    Begleiter A; Lin D; Larson KK; Lang J; Wu X; Cabral T; Taylor H; Guziec LJ; Kerr PD; Hasinoff BB; Guziec FS
    Oncol Rep; 2006 Jun; 15(6):1575-80. PubMed ID: 16685398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MDL 201,307: a novel benzothiazepine modulator of multiple drug resistance.
    Newman RA; Fan D; Munson HR; Martin LA; Ahmed NK
    J Exp Ther Oncol; 1996 Mar; 1(2):109-18. PubMed ID: 9414394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel multidrug resistance reversal agents.
    Berger D; Citarella R; Dutia M; Greenberger L; Hallett W; Paul R; Powell D
    J Med Chem; 1999 Jun; 42(12):2145-61. PubMed ID: 10377220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bis(7-amino-4-azaheptyl)dimethlysilane and bis(7-ethylamino-4-azaheptyl)dimethylsilane: inhibition of tumor cell growth in vitro and in vivo.
    Seiler N; Delcros JG; Vaultier M; Le Roch N; Havouis R; Douaud F; Moulinoux JP
    Cancer Res; 1996 Dec; 56(24):5624-30. PubMed ID: 8971167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent antitumor activity and improved pharmacological profile of ST1481, a novel 7-substituted camptothecin.
    De Cesare M; Pratesi G; Perego P; Carenini N; Tinelli S; Merlini L; Penco S; Pisano C; Bucci F; Vesci L; Pace S; Capocasa F; Carminati P; Zunino F
    Cancer Res; 2001 Oct; 61(19):7189-95. PubMed ID: 11585754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and cytotoxic evaluation of a new series of 3-substituted spiro[(dihydropyrazine-2,5-dione)-6,3'-(2',3'-dihydrothieno[2,3-b]naphtho-4',9'-dione)] derivatives.
    Gomez-Monterrey I; Campiglia P; Carotenuto A; Califano D; Pisano C; Vesci L; Lama T; Bertamino A; Sala M; di Bosco AM; Grieco P; Novellino E
    J Med Chem; 2007 Apr; 50(8):1787-98. PubMed ID: 17375902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of 2,4-diamino-6-(arylaminomethyl)pyrido[2,3-d]pyrimidines as inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase and as antiopportunistic infection and antitumor agents.
    Gangjee A; Adair OO; Queener SF
    J Med Chem; 2003 Nov; 46(23):5074-82. PubMed ID: 14584957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analogues of 10-deazaaminopterin and 5-alkyl-5,10-dideazaaminopterin with the 4-substituted 1-naphthoyl group in the place of 4-substituted benzoyl.
    Piper JR; Ramamurthy B; Johnson CA; Otter GM; Sirotnak FM
    J Med Chem; 1996 Jan; 39(2):614-8. PubMed ID: 8558535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationships of antineoplastic ring-substituted ether phospholipid derivatives.
    Papazafiri P; Avlonitis N; Angelou P; Calogeropoulou T; Koufaki M; Scoulica E; Fragiadaki I
    Cancer Chemother Pharmacol; 2005 Sep; 56(3):261-70. PubMed ID: 15856232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and characterization of OC144-093, a novel inhibitor of P-glycoprotein-mediated multidrug resistance.
    Newman MJ; Rodarte JC; Benbatoul KD; Romano SJ; Zhang C; Krane S; Moran EJ; Uyeda RT; Dixon R; Guns ES; Mayer LD
    Cancer Res; 2000 Jun; 60(11):2964-72. PubMed ID: 10850444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts.
    Gourdeau H; Genne P; Kadhim S; Bibeau L; Duchamp O; Ouellet F; deMuys JM; Bouffard DY; Attardo G
    Cancer Chemother Pharmacol; 2002 Dec; 50(6):490-6. PubMed ID: 12451476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-cytotoxicity relationship in a series of N-phosphorus substituted E,E-3,5-bis(3-pyridinylmethylene)- and E,E-3,5-bis(4-pyridinylmethylene)piperid-4-ones.
    Leonova ES; Makarov MV; Rybalkina EY; Nayani SL; Tongwa P; Fonari A; Timofeeva TV; Odinets IL
    Eur J Med Chem; 2010 Dec; 45(12):5926-34. PubMed ID: 21035234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.